DE68923387D1 - 2',3'-Dideoxy-2',2'-difluornucleoside. - Google Patents

2',3'-Dideoxy-2',2'-difluornucleoside.

Info

Publication number
DE68923387D1
DE68923387D1 DE68923387T DE68923387T DE68923387D1 DE 68923387 D1 DE68923387 D1 DE 68923387D1 DE 68923387 T DE68923387 T DE 68923387T DE 68923387 T DE68923387 T DE 68923387T DE 68923387 D1 DE68923387 D1 DE 68923387D1
Authority
DE
Germany
Prior art keywords
difluoronucleosides
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68923387T
Other languages
English (en)
Other versions
DE68923387T2 (de
Inventor
Larry Wayne Hertel
Cora Sue Grossman
Julian Stanley Kroin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE68923387D1 publication Critical patent/DE68923387D1/de
Application granted granted Critical
Publication of DE68923387T2 publication Critical patent/DE68923387T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68923387T 1988-02-16 1989-02-10 2',3'-Dideoxy-2',2'-difluornucleoside. Expired - Fee Related DE68923387T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15611688A 1988-02-16 1988-02-16

Publications (2)

Publication Number Publication Date
DE68923387D1 true DE68923387D1 (de) 1995-08-17
DE68923387T2 DE68923387T2 (de) 1996-01-25

Family

ID=22558157

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923387T Expired - Fee Related DE68923387T2 (de) 1988-02-16 1989-02-10 2',3'-Dideoxy-2',2'-difluornucleoside.

Country Status (16)

Country Link
EP (1) EP0329348B1 (de)
JP (1) JP3142128B2 (de)
KR (1) KR890013049A (de)
CN (1) CN1035117A (de)
AU (1) AU607840B2 (de)
CA (1) CA1312599C (de)
DE (1) DE68923387T2 (de)
DK (1) DK66389A (de)
ES (1) ES2075040T3 (de)
HU (1) HU203363B (de)
IL (1) IL89258A0 (de)
MX (1) MX14910A (de)
NZ (1) NZ227960A (de)
PH (1) PH25381A (de)
PT (1) PT89705B (de)
ZA (1) ZA891076B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
ZA907998B (en) * 1989-10-11 1991-07-31 Merrell Dow Pharma Inosine/guanosine derivatives as antineoplastic agents
AU636678B2 (en) * 1989-11-06 1993-05-06 Nycomed Imaging As Nucleoside derivatives
DE69133405T2 (de) * 1990-01-11 2005-07-07 Isis Pharmaceutical, Inc., Carlsbad Oligonukleotidderivate zur detektieren und modulation von rna aktivität und genexpression
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
JPH05505815A (ja) * 1990-04-04 1993-08-26 ニユコメド・イメージング・アクシエセルカペト ヌクレオシド誘導体
ZA914894B (en) * 1990-07-02 1992-04-29 Squibb & Sons Inc Purinyl and pyrimidinyl tetrahydrofurans
US6262241B1 (en) 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
WO2003059339A1 (en) 2002-01-15 2003-07-24 Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
AU2003291726A1 (en) 2002-11-04 2004-06-07 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US8299046B2 (en) 2006-11-17 2012-10-30 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
JP2010510243A (ja) 2006-11-17 2010-04-02 トラスティーズ オブ ダートマス カレッジ 三環系−ビス−エノン（ｔｂｅ）の合成および生物学的活性
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
EP2217247A4 (de) * 2007-11-06 2011-12-28 Pharmaessentia Corp Neue synthese von beta-nucleosiden
ES2718047T3 (es) 2008-01-11 2019-06-27 Reata Pharmaceuticals Inc Triterpenoides sintéticos y métodos de uso en el tratamiento de la enfermedad
JP5564490B2 (ja) 2008-04-18 2014-07-30 リアタ ファーマシューティカルズ インコーポレイテッド 抗炎症性ファルマコアを含む化合物および使用法
HUE033288T2 (en) 2008-04-18 2017-11-28 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
EA022588B1 (ru) 2008-04-18 2016-01-29 Ритэ Фамэсутикл, Инк. Антиоксидантные модуляторы воспаления: производные олеанолевой кислоты с насыщением в с-кольце
TWI453023B (zh) 2008-04-18 2014-09-21 Reata Pharmaceuticals Inc 抗氧化發炎調節劑：在ｃ－１７處具有胺基及其他修飾之齊墩果酸衍生物
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
MX360092B (es) 2012-04-04 2018-10-19 Halozyme Inc Terapia de combinación con un agente antihialuronano y un taxano orientado a tumor.
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
RU1787160C (ru) * 1986-12-24 1993-01-07 Эли Лилли Энд Компани Способ получени иммуноглобулинового конъюгата

Also Published As

Publication number Publication date
AU607840B2 (en) 1991-03-14
HUT49366A (en) 1989-09-28
JP3142128B2 (ja) 2001-03-07
AU2992689A (en) 1989-08-17
JPH01249797A (ja) 1989-10-05
MX14910A (es) 1993-11-01
CN1035117A (zh) 1989-08-30
PT89705B (pt) 1994-04-29
DK66389A (da) 1989-08-17
HU203363B (en) 1991-07-29
DE68923387T2 (de) 1996-01-25
NZ227960A (en) 1990-11-27
DK66389D0 (da) 1989-02-13
PT89705A (pt) 1989-10-04
IL89258A0 (en) 1989-09-10
CA1312599C (en) 1993-01-12
PH25381A (en) 1991-06-03
ZA891076B (en) 1990-10-31
EP0329348B1 (de) 1995-07-12
KR890013049A (ko) 1989-09-21
ES2075040T3 (es) 1995-10-01
EP0329348A3 (en) 1990-09-12
EP0329348A2 (de) 1989-08-23

Similar Documents

Publication Publication Date Title
DE68923387D1 (de) 2',3'-Dideoxy-2',2'-difluornucleoside.
LV5742B4 (lv) 3,5-divalizvietoti pirokatehina atvasinajumi
DE3764686D1 (de) N,n'-dihalo-2-imidazolidinone.
DE3783669D1 (de) Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile.
FI892534A0 (fi) Foerfarande foer framstaellning av 1,3-dioler av epoxider.
DE3763411D1 (de) 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate.
FI875619A0 (fi) 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner.
KR900700567A (ko) 2,3-디플루오로비페닐
DE3888530D1 (de) 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate.
FI892387A0 (fi) Mellanprodukter foer framstaellning av 1,4-dihydro-4-oxokinolin-3-karboxylsyraestrar.
DE3887281D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
NO882849L (no) 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
FI892132A0 (fi) Prolaekemedel av 2',3'-didehydro-2' 3'-dideoxynukleosider.
DE3765646D1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2-derivate.
FI881829A0 (fi) 1,3-dioxaner.
FI880552A (fi) Substituerade 2,6-substituerade pyridinfoereningar.
DE3888097D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE58903154D1 (de) 2,2-difluorcyclopropyl-derivate.
FI894455A (fi) 1,4-dihydropyridinderivat.
ATE121400T1 (de) Pyridyl-methylenamino-1,2,4-triazinone.
FI890483A (fi) Foerfarande foer framstaellning av sulfaterade alkanol- eller alkylfenoloxetylater med saenkt 1,4-dioxanhalt.
ES2015605B3 (es) 3,4-dihidro-2h-piranos.
DE68903983D1 (de) 1,6-diazaspiro(4,4)nonan-2,7-dion-derivate.
DE3788163D1 (de) 1,3,5-Trithian-Derivate.
FI880081A (fi) 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee